Menopausal hormone therapy can provide relief from symptoms such as hot flashes and improve quality of life for some patients. However, its use has been limited due to concerns about breast cancer risk. Recent studies have shown that the risks associated with hormone therapy may be lower than previously thought, particularly for younger women and those with certain types of breast cancer.

Deconstructing the Data

Some studies have found that hormone therapy can actually decrease the risk of breast cancer in certain cases. For example, a study published in the Journal of Clinical Oncology found that estrogen-only therapy was associated with a lower risk of breast cancer in women with estrogen-negative tumors. Another study found that hormone therapy was not associated with an increased risk of breast cancer in women who had undergone a hysterectomy.

Despite these findings, many healthcare providers remain cautious about prescribing hormone therapy due to concerns about breast cancer risk. However, the removal of the black box warning on hormone therapy by the FDA has encouraged a re-evaluation of its use. A risk-benefit analysis and shared decision-making between patients and healthcare providers can help determine the best course of treatment for each individual.

Original reporting: KTBS 3 (Shreveport) — read the source article.